Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach-Reference-Cited by-同舟云学术

Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach

Published:2020-07-23 Issue:9 Volume:24 Page:937-943
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Berardi Rossana¹,Goteri Gaia²,Brunelli Alessandro³,Pagliaretta Silvia¹,Paolucci Vittorio¹,Caramanti Miriam¹,Rinaldi Silvia¹,Refai Majed⁴,Pompili Cecilia³,Morgese Francesca¹,Torniai Mariangela¹,Marcantognini Giulia¹,Ricci Giulia¹,Mazzanti Paola¹,Onofri Azzurra¹,Bianchi Francesca¹,Sabbatini Armando⁴,Cascinu Stefano¹

Affiliation:

1. Medical Oncology, Università Politecnica delle Marche, Ospedali Riuniti Umberto I-GM Lancisi-G Salesi, Ancona, Italy

2. Section of Pathological Anatomy and Histopathology, Università Politecnica delle Marche, Ancona, Italy

3. Department of Thoracic Surgery, St. James’s University Hospital, Leeds, UK

4. Thoracic Surgery, Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I – GM Lancisi – G Salesi, Ancona, Italy

Funder

Bristol-Myers Squibb

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link